Abbott Laboratories
0
0
0%

Financials

Income statement

Fundamentals currency is USD
Fiscal date Sep 2025 Jun 2025 Mar 2025 Dec 2024
Total reported revenue 9.7B 9.5B 8.8B 9.3B
Cost of revenue 4.3B 4.1B 3.8B 4.2B
Gross profit 5.4B 5.4B 5.0B 5.1B
Operating expense
Research & development 652.4M 617.5M 609.9M 638.0M
Selling general and admin 2.6B 2.6B 2.6B 2.5B
Other operating expenses
Operating income 1.8B 1.7B 1.4B 1.6B
Non operating interest income
Income 65.6M 60.5M 69.8M 77.5M
Expense 103.1M 103.1M 111.6M 115.8M
Other income expense 142.2M 126.1M 114.1M 139.7M
Pretax income 1.9B 1.8B 1.5B 1.7B
Tax provision 456.5M 316.0M 385.8M -6.1B
Net income 1.4B 1.5B 1.1B 7.9B
Basic EPS 1.0 0.8 5.3
Diluted EPS 1.0 0.8 5.3
Basic average shares 1.5B 1.5B 1.5B
Diluted average shares 1.5B 1.5B 1.5B
EBITDA 2.6B 2.6B 2.3B 2.5B
Net income from continuing op. 1.4B 1.5B 1.1B 7.9B
Minority interests
Preferred stock dividends
Access the full /income_statement historical dataset via the API — starting from the Pro plan.
Market closed

Exchange is currently closed
Pre-market opens in 6 hours 21 minutes

01:38
00:00
08:55
17:35
23:59

Trading Hours (Monday - Friday):

Pre-market
08:00 - 08:55
Main market
08:55 - 17:35
Post-market
17:35 - 17:50
All times are displayed in the Europe/Vienna timezone (CET, UTC+01:00).